India’s fourth-largest pharma company posts strong domestic growth, 81.1% export surge, and 15% rise in consumer healthcare revenue led by flagship brands and new launches  Mankind Pharma Limited (BSE: 543904 | NSE: MANKIND), India’s fourth-largest pharmaceutical company by revenue, has reported consolidated revenue of ₹3,570 crore for the quarter ended June 30, 2025, marking a … Continue reading Mankind Pharma Reports ₹3,570 Cr Revenue in Q1FY26, Grows 24.5% YoY with 23.8% EBITDA Margin